Catalyst Wire Dossier Catalyst Wire Dossier

Symbyax

olanzapine and fluoxetine · Par Health USA, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Symbyax, covering 2007-06-13 to 2024-01-16. Get the full timeline:

Most recent: FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Par Health USA, LLC)

See pricing